Explore

Rapid ReadRapid Read
VA Study Reveals Increase in Veteran Depression and PTSD Screenings Amidst Declines in Suicide Risk and Alcohol Use

VA Study Reveals Increase in Veteran Depression and PTSD Screenings Amidst Declines in Suicide Risk and Alcohol Use

A recent study published in JAMA Network Open, involving over 3.6 million veterans receiving care through the VA, indicates a rise in positive screenings for depression and Post-Traumatic Stress Disorder (PTSD) between fiscal years 2021 and 2024. The study, led by researchers at the Stanford University School of Medicine and the VA Palo Alto Healthcare System, found that positive screening rates for depression increased from 8.8% to 9.6%, while PTSD screenings saw a more significant jump from 8.1% to 10.5%. This represents a 9% increase for depression and nearly a 30% increase for PTSD. Conversely, the study observed modest but statistically significant reductions in positive screening rates for suicide risk, which decreased from 0.7% to 0.5%, and alcohol-use disorder, which declined from 5.8% to 5.4%. These findings offer a comprehensive overview of mental health trends among veterans, highlighting areas requiring continued attention and resources within the VA system.
Rapid ReadRapid Read
New Study Reveals Gaps in Routine Lab Testing for High-Consequence Infectious Diseases at Frontline Hospitals

New Study Reveals Gaps in Routine Lab Testing for High-Consequence Infectious Diseases at Frontline Hospitals

A new study published in Infection Control & Hospital Epidemiology highlights significant challenges faced by many frontline acute care hospitals in safely performing routine laboratory tests for patients suspected of having high-consequence infectious diseases (HCIDs). Researchers from four Regional Emerging Special Pathogen Treatment Centers (RESPTCs), including NYC Health + Hospitals/Bellevue, Massachusetts General Hospital, Medstar Washington Hospital Center, and Johns Hopkins Hospital, collaborated with Boston University to survey 95 acute care hospitals in major metropolitan regions. The study, which received a 53% response rate from 50 hospitals, found that while tests like blood gas, hemoglobin/hematocrit, and lactate were commonly available, other crucial tests such as chemistry panels, complete blood counts (CBC) with differential, and malaria rapid diagnostic tests (RDTs) were less frequently accessible. This creates a critical mismatch between tests clinicians deem essential and what hospitals ...
Rapid ReadRapid Read
FDA Approves Ameluz with Red-Light Photodynamic Therapy for Superficial Basal Cell Carcinoma

FDA Approves Ameluz with Red-Light Photodynamic Therapy for Superficial Basal Cell Carcinoma

The Food and Drug Administration (FDA) has approved Ameluz (aminolevulinic acid hydrochloride) gel in conjunction with red-light photodynamic therapy (PDT) for the treatment of superficial basal cell carcinoma (BCC) in adults. This marks the first FDA approval of a photodynamic therapy specifically for a skin cancer, expanding its use beyond actinic keratosis, a precancerous condition. Basal cell carcinoma is the most prevalent form of skin cancer, typically managed through surgical interventions. The newly approved non-surgical option involves a two-step in-office procedure. First, a gel containing aminolevulinic acid is applied to the lesion and surrounding skin, which is preferentially absorbed by abnormal cells, making them light-sensitive. Following an incubation period, the area is exposed to a red-light lamp, activating the medication and initiating a chemical reaction that damages and destroys the targeted cancerous cells. This method aims to treat the cancer without requiring incisions or skin rem...
TrendlineTrendline
Vitalize Secures $31 Million to Scale AI-Powered Hospital Staffing and Scheduling System

Vitalize Secures $31 Million to Scale AI-Powered Hospital Staffing and Scheduling System

Vitalize Secures $31 Million to Scale AI-Powered Hospital Staffing and Scheduling System
TrendlineTrendline
Multiply Labs Secures $75 Million to Automate Drug Manufacturing

Multiply Labs Secures $75 Million to Automate Drug Manufacturing

Multiply Labs Secures $75 Million to Automate Drug Manufacturing
Rapid ReadRapid Read
High-Intensity Interval Training Shown to Reverse Coronary Plaque Growth

High-Intensity Interval Training Shown to Reverse Coronary Plaque Growth

A recent randomized controlled trial published in the European Journal of Preventive Cardiology has provided definitive evidence that high-intensity interval training (HIIT) can actively shrink atheromatous plaques in patients with coronary artery disease. The study tracked 60 patients who had recently undergone stent placement and found that those assigned to two weekly sessions of supervised HIIT experienced a measurable shrinkage in their coronary plaques, specifically a 9.0 cubic millimeter decrease in total atheroma volume. In contrast, patients following standard preventive guidelines saw a marginal increase of 3.0 cubic millimeters in plaque volume. This research marks a significant advancement in cardiovascular science, as it is the first study to use intravascular ultrasound to demonstrate that vigorous exercise can induce positive remodeling of coronary anatomy. The protocol involved a 10-minute warm-up, followed by four sets of 4-minute intervals at 85 to 95 percent of peak heart rate, separated...
Rapid ReadRapid Read
Plant-Based Diets Linked to Improved Kidney Function and Reduced Inflammatory Burden

Plant-Based Diets Linked to Improved Kidney Function and Reduced Inflammatory Burden

Dietary patterns emphasizing plant-based foods are associated with better kidney function and a reduced inflammatory burden compared to diets high in processed and red meat. This finding reflects overall dietary patterns rather than solely the protein source. A multi-cohort analysis also indicated that higher protein intake, from both plant and animal sources, was linked to a lower risk of all-cause mortality in older adults with mild-to-moderate chronic kidney disease (CKD), with mortality risk decreasing as protein intake increased. While plant-based protein is gaining recognition, current evidence is insufficient to definitively recommend a specific protein source for CKD populations. Individualized dietary approaches, medical treatment, and nutritional evaluation are crucial for preserving renal function in CKD patients. In healthy individuals, higher consumption of certain animal-protein-rich foods was associated with an increased risk of stage 3 CKD, whereas higher plant-based protein intake appeared...
Rapid ReadRapid Read
Continuous Glucose Monitors Demonstrate High Accuracy, Revolutionizing Diabetes Management

Continuous Glucose Monitors Demonstrate High Accuracy, Revolutionizing Diabetes Management

Continuous Glucose Monitoring (CGM) systems are proving to be highly accurate in managing glycemic variability, particularly for in-patients post-surgery or in intensive care units. Modern CGMs typically provide near-real-time glucose readings with an accuracy falling within 8% to 10% of laboratory blood values. This level of precision is considered sufficient for daily diabetes management decisions, significantly reducing the need for frequent fingerstick tests. While accuracy can vary based on the specific device, sensor placement, and duration of wear, CGMs have fundamentally transformed diabetes care by offering continuous insights into glucose trends. Factors such as dehydration, sensor compression, certain medications like high-dose vitamin C or acetaminophen, and the initial 24 hours post-insertion can influence readings, necessitating clinical judgment alongside device data.
Rapid ReadRapid Read
MIND Diet Improves Antioxidant Defenses and Mood in Diabetic Women with Insomnia

MIND Diet Improves Antioxidant Defenses and Mood in Diabetic Women with Insomnia

A recent randomized controlled trial conducted in Iran has demonstrated that a modified, calorie-restricted version of the MIND diet can significantly enhance antioxidant defenses and improve daily energy and emotional well-being in women with type 2 diabetes and insomnia symptoms. The study, published in BMC Endocrine Disorders, involved 44 women diagnosed with type 2 diabetes, reporting insomnia, and classified as overweight or obese. Participants were divided into two groups: one followed a standard low-calorie diet, while the other adhered to a modified MIND low-calorie diet. Over a twelve-week period, researchers observed significant increases in superoxide dismutase (SOD) and total antioxidant capacity (TAC) in the group following the modified MIND diet, indicating strengthened internal antioxidant defenses. Furthermore, this group reported feeling more energetic and emotionally stable compared to the control group, as measured by the SF-36 questionnaire. The MIND diet, a hybrid of the Mediterranean ...
Rapid ReadRapid Read
Postpartum GLP-1 Prescriptions Surge Nearly 24-Fold Among Privately Insured New Mothers, Raising Safety Concerns

Postpartum GLP-1 Prescriptions Surge Nearly 24-Fold Among Privately Insured New Mothers, Raising Safety Concerns

A recent study published in JAMA reveals a significant increase in GLP-1 medication prescriptions among privately insured new mothers in the United States. The share of women initiating GLP-1 drugs, such as Ozempic or Zepbound, within six months of delivery rose from 0.08% in the first half of 2018 to 1.9% in the first quarter of 2025, marking a nearly 24-fold increase. This analysis, led by Sih-Ting Cai of the Schaeffer Center and co-authors from Indiana University, reviewed insurance claims covering over one million births. The steepest rise was observed in women with type 2 diabetes, with prescriptions climbing from 2.3% to 16.9% by early 2025. Women with a history of gestational diabetes also saw an increase from 0.4% to 2.7%, while those with diagnosed obesity or overweight experienced the fastest relative growth, from 0.4% to 3.9%. The study notes that most women started these medications at least three months postpartum, and patients are advised to discontinue GLP-1 drugs during pregnancy.
Rapid ReadRapid Read
HHS Unveils AI Initiatives to Accelerate U.S. Clinical Trials

HHS Unveils AI Initiatives to Accelerate U.S. Clinical Trials

The U.S. Department of Health and Human Services (HHS) has announced a new program and three complementary projects aimed at significantly speeding up clinical trials through the integration of artificial intelligence (AI), advanced computational models, and real-time analysis. The core initiative, named SURPASS (Simulation-augmented, Real-time Platform Adaptive Seamless Trials), seeks to develop AI-powered platforms that will continuously and adaptively support clinical trial designs. This program includes the creation of a phaseless design engine to simulate trials for faster results with fewer patients, a continuous inference engine for real-time data analysis and trial adaptations, and an agentic AI operations layer to automate startup activities and data collection. These efforts are part of a broader strategy by HHS to transform U.S. clinical trials, building on previous initiatives like Operation TrialBlazer and the FDA's pilot program using AI for real-time clinical trial data monitoring. The goal ...
TrendlineTrendline
Japan Aims to Boost Pharmaceutical Industry Growth to G7 Average, Focuses on AI-Enabled Drug Discovery

Japan Aims to Boost Pharmaceutical Industry Growth to G7 Average, Focuses on AI-Enabled Drug Discovery

Japan Aims to Boost Pharmaceutical Industry Growth to G7 Average, Focuses on AI-Enabled Drug Discovery